Related Experiment Video
Updated: May 2, 2026
14:59
Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
7.0K
Low Lesion Clearance Rates in Neurocysticercosis: Is It Time to Review Guidelines?
Prabal Barman1, Naveen Sankhyan1, Renu Suthar1
1Department of Pediatrics, APC, PGIMER, Chandigarh, India.
Journal of Child Neurology
|November 4, 2024
Summary
Neurocysticercosis treatment guidelines based on CT scans may need updating. Post-treatment Magnetic Resonance Imaging (MRI) shows low lesion clearance rates in children, suggesting MRI should be a standard outcome measure.
Area of Science:
- Neurology
- Infectious Diseases
- Radiology
Background:
- Current neurocysticercosis treatment guidelines rely on computed tomography (CT) findings.
- Magnetic Resonance Imaging (MRI) offers higher resolution for evaluating treatment efficacy.
Purpose of the Study:
- To prospectively assess neurocysticercosis lesion clearance rates using MRI post-treatment.
- To compare MRI-based clearance rates with historical CT-based data.
Main Methods:
- A prospective observational study included newly diagnosed pediatric neurocysticercosis patients.
- Patients received antihelminthics and corticosteroids, followed by clinical and radiological evaluation at 6 months.
- Brain MRI was used to assess lesion resolution and compare with CT-based literature.
Main Results:
- Of 80 included children, 72 were evaluated at 6 months; 5 experienced seizure recurrence (6.2%).
- Overall lesion clearance on MRI was observed in 10% of children.
- In single-lesion neurocysticercosis cases (n=59), only 15.3% showed lesion resolution at 6 months.
Conclusions:
- Antihelminthic and corticosteroid treatment yields a low lesion resolution rate (15%) at 6 months in pediatric single-lesion neurocysticercosis.
- Existing treatment guidelines may require revision.
- MRI is proposed as a superior standard outcome measure for neurocysticercosis treatment efficacy.
